Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Dostupno od:

Hospira Australia Pty Ltd

INN (International ime):

Vinorelbine tartrate

Farmaceutski oblik:

Injection

Sastav:

Excipient Ingredients: water for injections

Administracija rute:

Intravenous

Jedinice u paketu:

1 X 5 mL

Razred:

Medicine Listed (Export Only)

Tip recepta:

Not scheduled. Not considered by committee

Terapijske indikacije:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Proizvod sažetak:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status autorizacije:

Licence status A

Datum autorizacije:

2008-05-21